Opaleye Management Inc. Eton Pharmaceuticals, Inc. Call Options Transaction History
Opaleye Management Inc.
- $390 Million
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ETON
# of Institutions
46Shares Held
8.16MCall Options Held
41KPut Options Held
1K-
Vanguard Group Inc Valley Forge, PA1.03MShares$8.86 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT941KShares$8.11 Million0.21% of portfolio
-
Westside Investment Management, Inc.585KShares$5.05 Million0.44% of portfolio
-
Acuitas Investments, LLC580KShares$5 Million1.08% of portfolio
-
Paradigm Capital Management Inc300KShares$2.59 Million0.05% of portfolio
About Eton Pharmaceuticals, Inc.
- Ticker ETON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,297,000
- Market Cap $218M
- Description
- Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...